Purchase Order 75N93023P01275
Award Date
9/14/23
Potential Completion Date
12/29/23
Potential Value
$21K
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Becton, Dickinson & Co
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Franklin Lakes, NJ 07417, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Becton, Dickinson and Company, doing business as BD, has been awarded a $21,000 purchase order contract by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to provide Whole Transcriptome Analysis reagent kits. The contract has a period of performance from September 14, 2023 through December 31, 2023. BD will deliver the requested reagent kits on a firm fixed price basis from its Franklin Lakes, New Jersey facility to support NIAID's research efforts. No...
Becton, Dickinson and Company, doing business as BD, has been awarded a purchase order contract valued at approximately $13,924.50 by the National Institutes of Health's National Institute of Allergy and Infectious Diseases. Under the terms of the contract, BD will provide BD Antibodies (AMBIS #2187100) to support NIH/NIAID's research efforts related to allergies and infectious diseases. Place of performance will be BD's facilities in Franklin Lakes, New Jersey, with work expected to be...
Becton, Dickinson and Company, doing business as BD, has been awarded a $21,000 firm fixed price purchase order by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to provide Whole Transcriptome Analysis amplification reagent kits. The reagent kits will support NIAID's research efforts under the description provided in the original solicitation. Performance will take place in Franklin Lakes, New Jersey over a four month period concluding at the end of...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $25,072.00 firm fixed price purchase order contract to Becton, Dickinson And Company (BD) for BD reagents to support vaccine research. The contract does not have a set-aside designation and is scheduled for completion on February 24, 2023. BD is a global medical technology company that provides instruments, reagents, and services for biomedical research and...
This is a $68,497.20 firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Becton, Dickinson And Company (BD) for the delivery of biological reagents. The contract has a period of performance through July 31, 2025. BD is a global medical technology company that has received numerous federal contract and subcontract awards to provide specialized equipment, consumables, and services in support of biomedical...
This firm fixed-price purchase order was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Becton, Dickinson And Company (BD) for the maintenance of BD equipment. The award has a potential value of $497,331.25 and a completion date of September 14, 2018. The place of performance is Franklin Lakes, New Jersey. BD is a global medical technology company that provides instruments, reagents, and...
Becton, Dickinson and Company (BD) has been awarded a firm fixed price purchase order by the Department of Health and Human Services' National Institutes of Health Clinical Center. Valued at eleven thousand six hundred seventy-one dollars and sixty cents ($11,671.60), this award is for the RHAPSODY Targeted mRNA ABSEQ Kit. Delivery is required by February 23, 2024. As a manufacturer and supplier of medical devices, instruments, reagents, and related products, BD will provide the requested...
This firm-fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) for $24,138.00. The contract is for the delivery of unspecified products or services related to BD's Biosciences division, which provides instruments, reagents, and services that support biomedical research and clinical applications through flow cytometry, cell imaging, and genomics...
This is a $6,532 firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD). The contract is not set aside for any particular business category. BD is a global medical technology company that provides instruments, reagents, and services supporting biomedical research and clinical applications, including through flow cytometry, cell imaging, and genomics...
Becton, Dickinson and Company, doing business as BD Biosciences, was awarded a $10,422 firm fixed price purchase order by the National Institutes of Health's National Institute of Arthritis and Musculoskeletal and Skin Diseases. Under this contract, BD Biosciences will provide systems and reagents in support of the NIH's biomedical research efforts from its place of performance in San Jose, California. As the prime contractor, BD Biosciences will leverage its expertise in life sciences...